Regulating the market in human research participants

被引：8

作者：

Lemmens, Trudo ^{[1
]}

Miller, Paul B.

机构：

[1] Univ Toronto, Fac Law, Toronto, ON M5S 1A1, Canada

[2] Univ Toronto, Fac Med, Toronto, ON M5S 1A1, Canada

来源：

PLOS MEDICINE | 2006年 / 3卷 / 08期

关键词：

D O I：

10.1371/journal.pmed.0030330

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1237 / 1241

页数：5

共 51 条

[31]

McNeill Paul, 1997, Bioethics, V11, P390

[32] Managing conflicts of interest in the conduct of clinical trials [J].

Morin, K ;

Rakatansky, H ;

Riddick, FA ;

Morse, LJ ;

O'Bannon, JM ;

Goldrich, NS ;

Ray, P ;

Weiss, M ;

Sade, RA ;

Spillman, MA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (01) :78-84

[33]

National Bioethics Advisory Committee, 2001, ETH POL ISS RES INV

[34]

*OFF INSP GEN US D, 2000, RECR HUM SUBJ PRESS

[35]

OTTO MA, 2003, RES INVESTIGATION VA

[36]

PAIR R, 2003, NY TIMES 0413, P24

[37] Ethical variability: Drug development and globalizing clinical trials [J].

Petryna, A .

AMERICAN ETHNOLOGIST, 2005, 32 (02) :183-197

[38]

PITTS G, 2003, GLOBE MAIL 0722, pB1

[39] Reform of drug regulation - Beyond an independent drug-safety board [J].

Ray, WA ;

Stein, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (02) :194-201

[40]

SONTAG D, 2005, NY TIMES 0206, P1

← 1 2 3 4 5 6 →